This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mendis, K N Articles by Carter, R Search for Related Content PubMed PubMed Citation Articles by Mendis, K N Articles by Carter, R

 Previous Article  |  Next Article 

Infect Immun. 1987 February; 55(2): 369-372

Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.

ABSTRACT

Immunity to malarial infections in human populations is known to affect the development of the asexual blood stages of the parasites in the human host and to be capable of conferring significant protection against morbidity and mortality due to the disease. In this study we show that during acute infection with Plasmodium vivax malaria, one of the two main malarial pathogens of humans, most individuals also develop immunity that suppresses the infectivity of the sexual stages of the parasite to mosquitoes. The immunity is antibody mediated and is directed against the parasites in the mosquito midgut shortly after ingestion of blood by a mosquito. This immunity could be expected to have significant effects on the natural transmission of P. vivax malaria.

This article has been cited by other articles:

• BHARTI, A. R., CHUQUIYAURI, R., BROUWER, K. C., STANCIL, J., LIN, J., LLANOS-CUENTAS, A., VINETZ, J. M. (2006). Experimental infection of the neotropical malaria vector anopheles darlingi by human patient-derived Plasmodium vivax in the peruvian Amazon.. Am J Trop Med Hyg 75: 610-616 [Abstract] [Full Text]  
• Haddad, D., Maciel, J., Kumar, N. (2006). Infection with Plasmodium berghei Boosts Antibody Responses Primed by a DNA Vaccine Encoding Gametocyte Antigen Pbs48/45. Infect. Immun. 74: 2043-2051 [Abstract] [Full Text]  
• BOUSEMA, J. T., ROEFFEN, W., VAN DER KOLK, M., DE VLAS, S. J., VAN DE VEGTE-BOLMER, M., BANGS, M. J., TEELEN, K., KURNIAWAN, L., MAGUIRE, J. D., BAIRD, J. K., SAUERWEIN, R. W. (2006). RAPID ONSET OF TRANSMISSION-REDUCING ANTIBODIES IN JAVANESE MIGRANTS EXPOSED TO MALARIA IN PAPUA, INDONESIA.. Am J Trop Med Hyg 74: 425-431 [Abstract] [Full Text]  
• AREVALO-HERRERA, M., SOLARTE, Y., ZAMORA, F., MENDEZ, F., YASNOT, M. F., ROCHA, L., LONG, C., MILLER, L. H., HERRERA, S. (2005). PLASMODIUM VIVAX: TRANSMISSION-BLOCKING IMMUNITY IN A MALARIA-ENDEMIC AREA OF COLOMBIA. Am J Trop Med Hyg 73: 38-43 [Abstract] [Full Text]  
• Hisaeda, H., Stowers, A. W., Tsuboi, T., Collins, W. E., Sattabongkot, J. S., Suwanabun, N., Torii, M., Kaslow, D. C. (2000). Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability of Plasmodium vivax To Infect Mosquitoes. Infect. Immun. 68: 6618-6623 [Abstract] [Full Text]  
• Good, M., Miller, L., Kumar, S, Quakyi, I., Keister, D, Adams, J., Moss, B, Berzofsky, J., Carter, R (1988). Limited immunological recognition of critical malaria vaccine candidate antigens. Science 242: 574-577 [Abstract]